A PEPTIC ULCER located in the DUODENUM.
Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
Penetration of a PEPTIC ULCER through the wall of DUODENUM or STOMACH allowing the leakage of luminal contents into the PERITONEAL CAVITY.
Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT.
Vagal denervation of that part of the STOMACH lined with acid-secreting mucosa (GASTRIC MUCOSA) containing the GASTRIC PARIETAL CELLS. Since the procedure leaves the vagal branches to the antrum and PYLORUS intact, it circumvents gastric drainage required with truncal vagotomy techniques.
The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651)
A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
The interruption or removal of any part of the vagus (10th cranial) nerve. Vagotomy may be performed for research or for therapeutic purposes.
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
Hydrochloric acid present in GASTRIC JUICE.
A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.
Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.
An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.
Endoscopic examination, therapy or surgery of the luminal surface of the duodenum.
A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.
A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.
Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.
The region of the STOMACH at the junction with the DUODENUM. It is marked by the thickening of circular muscle layers forming the pyloric sphincter to control the opening and closure of the lumen.
Gastric analysis for determination of free acid or total acid.
Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.
A metallic element that has the atomic symbol Bi, atomic number 83 and atomic weight 208.98.
The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS).
A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
A variety of surgical reconstructive procedures devised to restore gastrointestinal continuity, The two major classes of reconstruction are the Billroth I (gastroduodenostomy) and Billroth II (gastrojejunostomy) procedures.
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).
Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Impaired digestion, especially after eating.
Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER.
Proenzymes secreted by chief cells, mucous neck cells, and pyloric gland cells, which are converted into pepsin in the presence of gastric acid or pepsin itself. (Dorland, 28th ed) In humans there are 2 related pepsinogen systems: PEPSINOGEN A (formerly pepsinogen I or pepsinogen) and PEPSINOGEN C (formerly pepsinogen II or progastricsin). Pepsinogen B is the name of a pepsinogen from pigs.
Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS.
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.
A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.
The return of a sign, symptom, or disease after a remission.
A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.
Endoscopic examination, therapy or surgery of the interior of the stomach.
A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.
A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.
Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).
A basic aluminum complex of sulfated sucrose.
A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.
Therapy with two or more separate preparations given for a combined effect.
Pathological processes involving the STOMACH.
A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.
Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.
Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
A genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivative, CARBENOXOLONE.
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)
Bilateral dissection of the abdominal branches of the vagus nerve. It is used frequently in the surgical management of duodenal and gastric ulcers, as well as in physiologic studies of gastrointestinal secretion and motility.
Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
Endoscopic examination, therapy or surgery of the gastrointestinal tract.
An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8.
A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
Endoscopic examination, therapy or surgery of the digestive tract.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
A plant species of the genus ATROPA, family SOLANACEAE that contains ATROPINE; SCOPOLAMINE; BELLADONNA ALKALOIDS and other SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for SOLANUM.
An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
Vomiting of blood that is either fresh bright red, or older "coffee-ground" in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.
Any substances taken in by the body that provide nourishment.
Tumors or cancer of the STOMACH.
Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants.
Substances that reduce the growth or reproduction of BACTERIA.
The black, tarry, foul-smelling FECES that contain degraded blood.
A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.
Elements of limited time intervals, contributing to particular results or situations.
Control of bleeding performed through the channel of the endoscope. Techniques include use of lasers, heater probes, bipolar electrocoagulation, and local injection. Endoscopic hemostasis is commonly used to treat bleeding esophageal and gastrointestinal varices and ulcers.
Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans (analogous to the ketones). (From Hackh's Chemical Dictionary, 4th ed)
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Any tests done on exhaled air.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.
A condition in which there is a change of one adult cell type to another similar adult cell type.
A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.
A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597)
A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.

Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal ulcer. (1/1325)

BACKGROUND: Helicobacter pylori affects gastric epithelium integrity by acceleration of apoptosis. However, it remains unclear what product of the bacteria causes apoptosis, or whether or not the apoptosis is involved in the development of ulcers. AIMS: To elucidate the factor from H pylori that causes acceleration of apoptosis and the role of apoptosis in the development of duodenal ulcer in H pylori infection. PATIENTS: Five H pylori negative healthy volunteers, 47 H pylori positive patients with duodenal ulcer, and 35 H pylori positive patients with gastric ulcer. METHODS: An endoscopic examination was carried out to diagnose ulcers and determine their clinical stage. To analyse apoptosis, a cell cycle analysis was performed using biopsy specimens. RESULTS: There was a significant correlation between the urease activity of the H pylori strain and the level of apoptosis induced by this bacterial strain. Moreover, in duodenal ulcer patients infected with H pylori, the patients with an active ulcer exhibited a significantly higher level of apoptosis than those with ulcers at both the healing and scarring stages. CONCLUSION: These findings suggest that acceleration of apoptosis in the antral mucosa caused by the urease of H pylori plays a crucial role in the development of ulcers in the duodenum.  (+info)

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study. (2/1325)

BACKGROUND: Rabeprazole sodium is the newest member of a class of substituted benzimidazole molecules known as proton pump inhibitors. Other proton pump inhibitors have been shown to be effective in healing active duodenal ulcer. METHOD: This randomized, double-blind, multicentre study, conducted at 25 European sites, compared the efficacy and tolerability of rabeprazole and omeprazole in patients with active duodenal ulcers. One hundred and two patients with active duodenal ulcer received rabeprazole 20 mg and 103 patients omeprazole 20 mg once daily for 2 or 4 weeks, with ulcer healing monitored by endoscopy. RESULTS: After 2 weeks, complete ulcer healing was documented in 69% of patients given rabeprazole 20 mg and in 62% of patients given omeprazole 20 mg (N.S.). After 4 weeks, healing rates were 98% in the rabeprazole group and 93% in the omeprazole group (P = 0.083). Rabeprazole-treated patients had significantly greater improvement in daytime pain symptom relief than those treated with omeprazole at the conclusion of the study (P = 0.038). Both drugs were well tolerated over the 4-week treatment period. Mean changes from baseline to end-point in fasting serum gastrin were significantly greater in the rabeprazole group, but at end-point mean values were well within normal limits for both groups. No clinically meaningful changes or other between-group differences were observed in laboratory parameters. CONCLUSION: In this study, rabeprazole produced healing rates equivalent to omeprazole at weeks 2 and 4, and provided significantly greater improvement in daytime pain. Both treatments were well tolerated.  (+info)

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. (3/1325)

AIM: To investigate the efficacy of two omeprazole triple therapies for the eradication of Helicobacter pylori, ulcer healing and ulcer relapse during a 6-month treatment-free period in patients with active duodenal ulcer. METHODS: This was a double-blind, randomized study in 15 centres across Canada. Patients (n = 149) were randomized to omeprazole 20 mg once daily (O) or one of two 1-week b. d. eradication regimens: omeprazole 20 mg, metronidazole 400 mg and clarithromycin 250 mg (OMC) or omeprazole 20 mg, amoxycillin 1000 mg and clarithromycin 500 mg (OAC). All patients were treated for three additional weeks with omeprazole 20 mg once daily. Ulcer healing was assessed by endoscopy after 4 weeks of study therapy. H. pylori eradication was determined by a 13C-urea breath test and histology, performed at pre-entry, at 4 weeks after the end of all therapy and at 6 months. RESULTS: The intention-to-treat (intention-to-treat) analysis contained 146 patients and the per protocol (per protocol) analysis, 114 patients. The eradication rates were (intention-to-treat/per protocol): OMC-85% and 92%, OAC-78% and 87% and O-0% (O). Ulcer healing (intention-to-treat) was greater than 90% in all groups. The differences in the eradication and relapse rates between O vs. OMC and O vs. OAC were statistically significant (all, P < 0.001). Treatment was well tolerated and compliance was high. CONCLUSION: The OMC and OAC 1-week treatment regimens are safe and effective for eradication, healing and the prevention of relapse in duodenal ulcer patients.  (+info)

The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. (4/1325)

AIM: To assess the influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate-based triple therapy regimens in two consecutive studies. METHODS: In the first study, patients with a culture-proven Helicobacter pylori infection were treated with ranitidine bismuth citrate 400 mg, metronidazole 500 mg, and clarithromycin 500 mg, all twice daily for 1 week (RMC). In the second study, amoxycillin 1000 mg was substituted for clarithromycin (RMA). Susceptibility testing for metronidazole was performed with the E-test. Follow-up endoscopy was performed after >/= 4 weeks. Antral biopsy samples were taken for histology and urease test, and culture and corpus samples for histology and culture. RESULTS: 112 patients, 53 males, age 55 +/- 14 years (39 duodenal ulcer, 7 gastric ulcer and 66 gastritis) were treated with RMC, and 89 patients, 52 males, age 58 +/- 15 years (23 duodenal ulcer, 7 gastric ulcer and 59 gastritis) were treated with RMA. For RMC, intention-to-treat eradication results were 98% (59/60, 95% CI: 91-100%) and 95% (20/21, 95% CI: 76-100%) for metronidazole susceptible and resistant strains, respectively (P = 0.45). For RMA these figures were 87% (53/61, 95% CI: 76-94%) for metronidazole susceptible strains and 22% (2/9, 95% CI: 3-60%) for resistant strains (P = 0.0001). CONCLUSION: Both regimens are effective in metronidazole susceptible strains. However, in contrast to the amoxycillin-containing regimen, that containing clarithromycin is also effective in resistant strains.  (+info)

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. (5/1325)

BACKGROUND: The effectiveness of Helicobacter pylori eradication treatment and long term acid suppression maintenance in the natural course of duodenal ulcer has not been directly compared. AIM: To compare in a prospective randomized study the effectiveness of H. pylori eradication on the prevention of recurrence of duodenal ulcer with long-term maintenance acid suppression therapy. METHODS: One hundred and fourteen duodenal ulcer patients were randomized to the treatment over a 12-month period. Fifty-seven of them received triple therapy consisting of 1 g sucralfate q.d.s. for 28 days, 300 mg metronidazole q.d.s. for 14 days and 250 mg clarithromycin q.d.s. for 14 days. Another 57 received 20 mg omeprazole q.d.s. for 12 months. An upper endoscopy was performed before treatment, at 6 weeks, and 2, 6 and 12 months after the first endoscopy. Side-effects were self-recorded and clinical follow-ups were arranged for up to 4.25 years. RESULTS: The ulcer healing rate was 90.2% (95% confidence interval (95% CI): 79-97%) in the omeprazole group at 6 weeks as compared to 83.3% (95% CI: 70-93%) in the triple therapy group (P = 0.38). There was a higher success rate of pain control in the omeprazole group. Side-effects were more frequently reported and compliance was poorer in the triple therapy group during the first 4 weeks. During follow-up, more relapses were seen in the omeprazole group (9.8%, 95% CI: 3-21%) than the triple therapy group (4.2%, 95% CI: 1-13%) at 1 year (P = 0.44). All relapses were due to the persistence of H. pylori infection. At the 1 year follow-up, none of the patients who were H. pylori negative had an endoscopic relapse compared to 7 out of 56 patients who remained H. pylori positive (12.5%, 95% CI: 5-24%, P = 0.018). After a mean follow-up of 4.07 years, none of those who remained H. pylori negative had an ulcer relapse while the 11 out of 41 who remained H. pylori positive had an ulcer relapse (26.8%, 95% CI 14-43, P = 0. 0005). CONCLUSIONS: Both regimens were highly effective in healing ulcers. The eradication of H. pylori infection was associated with more side-effects and poor compliance but was more effective than the maintenance therapy in reducing the recurrence of duodenal ulcers. For the prevention of ulcer recurrence, testing of H. pylori status after triple therapy is more important than maintenance therapy.  (+info)

Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. (6/1325)

BACKGROUND: A furazolidone-containing therapeutic regimen for Helicobacter pylori infection has attracted special interest in the face of a rising world-wide metronidazole resistant H. pylori, and the expense of currently used antimicrobial regimens. AIM: To evaluate the efficacy of furazolidone-containing regimens in eradicating H. pylori. METHODS: One-hundred and forty H. pylori positive patients with endoscopically confirmed duodenal ulcer or functional dyspepsia received one of four different regimens to eradicate H. pylori. In the first trial, the patients were randomly assigned to receive a 1-week course of furazolidone 100 mg b.d. and clarithromycin 250 mg b.d., with either tripotassium dicitrato bismuthate (TDB) 240 mg b.d. (FCB group) or lansoprazole 30 mg daily (FCL group). In the second trial, the patients were randomly assigned to receive a 1-week course of clarithromycin 250 mg b.d. and omeprazole 20 mg daily, with either furazolidone 100 mg b.d. (FCO group) or metronidazole 400 mg b.d. (MCO group). Endoscopy was repeated 4 weeks following completion of therapy with re-assessment of H. pylori status on gastric biopsies by histology and culture. RESULTS: Four patients (1 in FCB, 1 in FCO and 2 in MCO groups) dropped out because they refused a follow-up endoscopy. Eradication rates of H. pylori on an intention-to-treat basis in the FCB, FCL, FCO and MCO groups were 91% (32/35, 95% CI: 82-99%), 91% (32/35, CI: 82-99%), 86% (30/35, CI: 74-97%) and 74% (26/35, CI: 60-89%) (all P > 0.05), respectively. Mild side-effects occurred in 15% of the 140 patients. In MCO group, the eradication rate in the patients infected with metronidazole-sensitive isolates of H. pylori was 86%, but dropped to 67% in those with metronidazole-resistance strains (P = 0.198). CONCLUSION: One-week regimens containing furazolidone and clarithromycin in combination with TDB or a proton pump inhibitor fulfil the criteria for successful H. pylori therapy.  (+info)

Proximal gastric vagotomy: effects of two operative techniques on clinical and gastric secretory results. (7/1325)

PGV performed in 39 patients by separating the lesser omentum from the stomach beginning 6 or 7 cm proximal to the pylorus and skeletonizing the distal 1 to 2 cm of esophagus was followed by 15.4% of proven and 10.2 of suspected recurrent ulcers. Insulin tests were done during the first 3 months postoperatively on 31 of the patients, including the 6 with proven and the 4 with suspected recurrent ulcers. The peak acid output to insulin minus tha basal acid output (PAOI-BAO) was less than 5 mEq/hr in 16 cases (52%) and from 5 to 25 mEq/hr in the remaining 15 cases. In 6 patients with proven recurrent ulcer, PAOI-BAO averaged 21.9 mEq/hr (range, 11.3 to 41.8); in the 4 patients with suspected recurrence, 9.5 (range, 4.4 to 11.8). The operative technique was changed in one respect; the distal 5 to 7.5 cm of the esophagus was skeletonized. In 14 patients, the mean PAOI-BAO +/- S.E. within 3 months of PGV was 1985 +/- 0.7 mEq/hr, and 13 of 14 values were less than 5 mEq/hr. One patient developed recurrent ulcer and required re-operation; this patient's value for PAO-BAO was 1.8 mEq/hr. The results show quantitatively that great differences in the completeness of PGV result from differences in the periesophageal dissection and emphasize its importance if optimal results are to be obtained and, especially, if the efficacy of the operation is to be judged.  (+info)

Prognosis of gastric ulcer: twenty-five year followup. (8/1325)

Four hundred twenty-two patients with gastric ulcer treated during 1950-1960 were followed up to 25 years with a mean followup of 9 years. Nonoperative treatment was used in 59% with a hospital mortality of 35%, one-third of these deaths being directly due to gastric ulcer perforation or hemorrhage. Operative treatment was used in 41% of patients. The most common operation (86%) was gastric resection without vagotomy. Overall operative mortality was 16%; 34% for emergency procedures and 6% for elective procedures. Cachexia seemed to be the most important factor related to operative mortality. Nonoperative treatment resulted in more than twice the hospital mortality compared to operative treatment. Approximately one-half of all patients treated non-operatively had a recurrent gastric ulcer at some time during this study. The recurrence rate following definitive gastric resection was 1.3% compared with 16% during nonoperative therapy. Three-fourths of recurrences occurred later than two years and nearly half of recurrences after more than 5 years of followup. Patients with a prior history of overt bleeding from gastric ulcer disease particularly were at risk for further bleeding. There were coincidental duodenal ulcers in 10% of our patients and a 0.8% incidence of gastric cancer during followup. Long term followup demonstrates the superiority of operative treatment of gastric ulcer and also reveals the continuous propensity of such ulcers to recurrence following nonoperative treatment. Earlier elective operation in patients with overt bleeding, recurrence or persisting symptoms should decrease overall mortality and result in a lower overall long-term risk of ulcer complications.  (+info)

The main causes of duodenal ulcers are:

1. Infection with the bacterium Helicobacter pylori (H. pylori)
2. Overuse of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen
3. Excessive alcohol consumption
4. Smoking
5. Zollinger-Ellison syndrome, a rare condition that causes the stomach to produce too much acid

Symptoms of duodenal ulcers may include:

1. Abdominal pain, which can be worse when eating or at night
2. Nausea and vomiting
3. Bloating and gas
4. Acid reflux
5. Weight loss

Diagnosis of a duodenal ulcer typically involves a combination of endoscopy, where a flexible tube with a camera is inserted through the mouth to visualize the inside of the digestive tract, and breath tests to detect H. pylori infection.

Treatment for duodenal ulcers usually involves eradication of H. pylori infection, if present, and avoidance of NSAIDs and other irritants. Antacids or acid-suppressing medications may also be prescribed to help reduce symptoms and allow the ulcer to heal. In severe cases, surgery may be necessary.

Prevention of duodenal ulcers includes:

1. Avoiding NSAIDs and other irritants
2. Eradicating H. pylori infection
3. Quitting smoking and excessive alcohol consumption
4. Managing stress
5. Eating a healthy diet with plenty of fruits, vegetables, and whole grains

Prognosis for duodenal ulcers is generally good if treated promptly and effectively. However, complications such as bleeding, perforation, and obstruction can be serious and potentially life-threatening. It is important to seek medical attention if symptoms persist or worsen over time.

In conclusion, duodenal ulcers are a common condition that can cause significant discomfort and disrupt daily life. While they can be caused by a variety of factors, H. pylori infection is the most common underlying cause. Treatment typically involves eradication of H. pylori infection, avoidance of NSAIDs and other irritants, and management of symptoms with antacids or acid-suppressing medications. Prevention includes avoiding risk factors and managing stress. With prompt and effective treatment, the prognosis for duodenal ulcers is generally good. However, complications can be serious and potentially life-threatening, so it is important to seek medical attention if symptoms persist or worsen over time.

Stomach ulcers are caused by an imbalance between the acid and mucus in the stomach, which can lead to inflammation and damage to the stomach lining. Factors that can contribute to the development of a stomach ulcer include:

* Infection with the bacterium Helicobacter pylori (H. pylori)
* Overuse of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen
* Excessive alcohol consumption
* Smoking
* Stress
* Zollinger-Ellison syndrome, a rare condition that causes the stomach to produce too much acid.

Symptoms of a stomach ulcer may include:

* Pain in the upper abdomen, often described as a burning or gnawing sensation
* Nausea and vomiting
* Bloating and gas
* Abdominal tenderness
* Loss of appetite
* Weight loss

Treatment for stomach ulcers typically involves antibiotics to kill H. pylori, if present, and acid-suppressing medications to reduce the amount of acid in the stomach. In severe cases, surgery may be necessary. Lifestyle changes, such as avoiding NSAIDs, alcohol, and smoking, can also help manage symptoms and prevent recurrence.

Preventive measures for stomach ulcers include:

* Avoiding NSAIDs and other irritating substances
* Using acid-suppressing medications as needed
* Maintaining a healthy diet and lifestyle
* Managing stress
* Avoiding excessive alcohol consumption

It is important to seek medical attention if symptoms persist or worsen over time, as stomach ulcers can lead to complications such as bleeding, perforation, and obstruction. Early diagnosis and treatment can help prevent these complications and improve outcomes.

A peptic ulcer is a break in the lining of the stomach or duodenum (the first part of the small intestine), which can cause pain and bleeding. The stomach acid and digestive enzymes flowing through the ulcer can irritate the surrounding tissue, leading to inflammation and discomfort.

Peptic ulcers are commonly caused by an infection with Helicobacter pylori (H. pylori) bacteria or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or aspirin. Other contributing factors include stress, smoking, and excessive alcohol consumption.

Symptoms of a peptic ulcer may include abdominal pain, nausea, vomiting, and loss of appetite. Treatment options typically involve antibiotics to eradicate H. pylori infection or stopping NSAID use, along with medications to reduce acid production in the stomach and protect the ulcer from further damage. Surgery may be necessary for severe cases or if other treatments fail.

Prevention methods include avoiding NSAIDs, maintaining a healthy lifestyle, managing stress, and getting regular screenings for H. pylori infection. Early detection and proper treatment can help alleviate symptoms and prevent complications such as ulcer perforation or bleeding.

In summary, peptic ulcers are painful and potentially harmful conditions that can be caused by various factors. Proper diagnosis and treatment are essential to prevent complications and improve quality of life.

The symptoms of a peptic ulcer perforation may include sudden and severe abdominal pain, nausea, vomiting, fever, and difficulty breathing. If you suspect that you or someone else is experiencing these symptoms, it is essential to seek medical attention immediately. Diagnosis is typically made through a combination of physical examination, blood tests, and imaging studies such as X-rays or CT scans.

Treatment for a peptic ulcer perforation typically involves surgery to repair the hole and clean out any infected tissue. In some cases, this may involve opening up the abdominal cavity (laparotomy) or using minimally invasive techniques such as laparoscopy. Antibiotics and other medications may also be used to help manage infection and other complications.

Prevention is key in avoiding peptic ulcer perforation. This includes avoiding NSAIDs (such as aspirin, ibuprofen, and naproxen) and other medications that can irritate the stomach lining, eating a healthy diet, managing stress, and not smoking. If you have a peptic ulcer, it is crucial to follow your healthcare provider's recommendations for treatment and follow-up care to avoid complications.

A peptic ulcer hemorrhage is a serious complication that occurs when an ulcer in the stomach or duodenum (the first part of the small intestine) bleeds. The bleeding can be severe and life-threatening, and it requires immediate medical attention.

Causes:

There are several factors that can contribute to the development of a peptic ulcer hemorrhage, including:

1. Infection with Helicobacter pylori (H. pylori) bacteria
2. Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen
3. Excessive alcohol consumption
4. Smoking
5. Zollinger-Ellison syndrome, a rare condition that causes the stomach to produce too much acid
6. Crohn's disease, an inflammatory bowel disorder
7. Ulcers caused by other conditions such as cancer, trauma, or radiation therapy

Symptoms:

The symptoms of a peptic ulcer hemorrhage can vary depending on the severity of the bleeding, but they may include:

1. Vomiting blood or coffee ground-like material
2. Dark, tarry stools
3. Abdominal pain that worsens over time
4. Weakness and lightheadedness due to blood loss
5. Pale, cool, or clammy skin

Diagnosis:

To diagnose a peptic ulcer hemorrhage, a healthcare provider may use one or more of the following tests:

1. Endoscopy: A thin, flexible tube with a camera and light on the end is inserted through the mouth to visualize the stomach and duodenum.
2. Gastrointestinal (GI) bleeding scale: This is a system used to assess the severity of bleeding based on symptoms and physical examination findings.
3. Blood tests: These may be used to check for signs of anemia, such as low red blood cell count or high levels of hemoglobin in the urine.
4. Upper GI series: This is a test that uses X-rays to visualize the esophagus, stomach, and duodenum.
5. CT scan: A computerized tomography (CT) scan may be used to rule out other causes of bleeding, such as a ruptured ulcer or tumor.

Treatment:

The goal of treatment for a peptic ulcer hemorrhage is to stop the bleeding and prevent further complications. Treatment options may include:

1. Medications: These may include antacids, H2 blockers, or proton pump inhibitors to reduce acid production and protect the ulcer from further irritation.
2. Endoscopy: A healthcare provider may use an endoscope to locate the source of bleeding and apply a topical treatment such as cautery, sclerotherapy, or argon plasma coagulation to stop the bleeding.
3. Interventional radiology: In some cases, a healthcare provider may use interventional radiology techniques to embolize (block) the blood vessel feeding the ulcer. This can help stop the bleeding and promote healing.
4. Surgery: In rare cases where other treatments have failed, surgery may be necessary to repair the ulcer or remove any damaged tissue.

Prevention:

To prevent peptic ulcer hemorrhage from recurring, it is important to take steps to prevent further irritation of the ulcer and promote healing. This may include:

1. Avoiding NSAIDs and aspirin: These medications can irritate the stomach lining and increase the risk of bleeding.
2. Avoiding alcohol and smoking: Both of these can irritate the stomach lining and impair healing.
3. Eating a healthy diet: Avoiding spicy or acidic foods and eating smaller, more frequent meals can help reduce symptoms and promote healing.
4. Managing stress: Stress can exacerbate peptic ulcer symptoms and impair healing.
5. Taking medications as directed: If your healthcare provider has prescribed medication to treat your peptic ulcer, it is important to take it as directed.
6. Follow-up care: Regular follow-up appointments with your healthcare provider can help monitor your condition and ensure that any complications are addressed promptly.

1. Gastritis: Inflammation of the stomach lining, which can be acute or chronic.
2. Peptic ulcer disease: Ulcers in the stomach or duodenum (the first part of the small intestine) that are caused by H. pylori infection.
3. Gastric adenocarcinoma: A type of stomach cancer that is associated with long-term H. pylori infection.
4. Mucosa-associated lymphoid tissue (MALT) lymphoma: A rare type of cancer that affects the immune cells in the stomach and small intestine.
5. Gastroesophageal reflux disease (GERD): A condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn and regurgitation.
6. Helicobacter pylori-associated chronic atrophic gastritis: A type of chronic inflammation of the stomach lining that can lead to stomach ulcers and stomach cancer.
7. Post-infectious irritable bowel syndrome (PI-IBS): A condition that develops after a gastrointestinal infection, characterized by persistent symptoms such as abdominal pain, bloating, and changes in bowel habits.

Helicobacter infections are typically diagnosed through endoscopy, where a flexible tube with a camera and light on the end is inserted into the stomach and small intestine to visualize the mucosa and look for signs of inflammation or ulcers. Laboratory tests such as breath tests and stool tests may also be used to detect the presence of H. pylori bacteria in the body. Treatment typically involves a combination of antibiotics and acid-suppressing medications to eradicate the infection and reduce symptoms.

Preventing Helicobacter Infections:

While it is not possible to completely prevent Helicobacter infections, there are several measures that can be taken to reduce the risk of developing these conditions:

1. Practice good hygiene: Wash your hands regularly, especially before eating and after using the bathroom.
2. Avoid close contact with people who have Helicobacter infections.
3. Avoid sharing food, drinks, or utensils with people who have Helicobacter infections.
4. Avoid consuming undercooked meat, especially pork and lamb.
5. Avoid consuming raw shellfish, especially oysters.
6. Avoid consuming unpasteurized dairy products.
7. Avoid alcohol and caffeine, which can irritate the stomach lining and increase the risk of developing Helicobacter infections.
8. Maintain a healthy diet that is high in fiber and low in fat.
9. Manage stress, as stress can exacerbate symptoms of Helicobacter infections.
10. Practice good oral hygiene to prevent gum disease and other oral infections that can increase the risk of developing Helicobacter infections.

Conclusion:

Helicobacter infections are a common cause of stomach ulcers, gastritis, and other gastrointestinal disorders. These infections are caused by the bacteria Helicobacter pylori, which can be found in the stomach lining and small intestine. While these infections can be difficult to diagnose, a combination of endoscopy, blood tests, and stool tests can help confirm the presence of Helicobacter bacteria. Treatment typically involves a combination of antibiotics and acid-suppressing medications to eradicate the infection and reduce symptoms. Preventive measures include practicing good hygiene, avoiding close contact with people who have Helicobacter infections, and maintaining a healthy diet.

Symptoms of leg ulcers may include:

* Pain or tenderness in the affected area
* Redness or swelling around the wound
* Discharge or oozing of fluid from the wound
* A foul odor emanating from the wound
* Thickening or hardening of the skin around the wound

Causes and risk factors for leg ulcers include:

* Poor circulation, which can be due to conditions such as peripheral artery disease or diabetes
* Injury or trauma to the lower leg
* Infection, such as cellulitis or abscesses
* Skin conditions such as eczema or psoriasis
* Poorly fitting or compression garments
* Smoking and other lifestyle factors that can impair healing

Diagnosis of a leg ulcer typically involves a physical examination and imaging tests, such as X-rays or ultrasound, to rule out other conditions. Treatment may involve debridement (removal of dead tissue), antibiotics for infection, and dressing changes to promote healing. In some cases, surgery may be necessary to remove infected tissue or repair damaged blood vessels.

Prevention is key in managing leg ulcers. This includes maintaining good circulation, protecting the skin from injury, and managing underlying conditions such as diabetes or peripheral artery disease. Compression stockings and bandages can also be used to help reduce swelling and promote healing.

Prognosis for leg ulcers varies depending on the severity of the wound and underlying conditions. With proper treatment and care, many leg ulcers can heal within a few weeks to months. However, some may take longer to heal or may recur, and in severe cases, amputation may be necessary.

Overall, managing leg ulcers requires a comprehensive approach that includes wound care, debridement, antibiotics, and addressing underlying conditions. With proper treatment and care, many leg ulcers can heal and improve quality of life for those affected.

There are several factors that can contribute to the development of pressure ulcers, including:

1. Pressure: Prolonged pressure on a specific area of the body can cause damage to the skin and underlying tissue.
2. Shear: Movement or sliding of the body against a surface can also contribute to the development of pressure ulcers.
3. Friction: Rubbing or friction against a surface can damage the skin and increase the risk of pressure ulcers.
4. Moisture: Skin that is wet or moist is more susceptible to pressure ulcers.
5. Incontinence: Lack of bladder or bowel control can lead to prolonged exposure of the skin to urine or stool, increasing the risk of pressure ulcers.
6. Immobility: People who are unable to move or change positions frequently are at higher risk for pressure ulcers.
7. Malnutrition: A diet that is deficient in essential nutrients can impair the body's ability to heal and increase the risk of pressure ulcers.
8. Smoking: Smoking can damage blood vessels and reduce blood flow to the skin, increasing the risk of pressure ulcers.
9. Diabetes: People with diabetes are at higher risk for pressure ulcers due to nerve damage and poor circulation.
10. Age: The elderly are more susceptible to pressure ulcers due to decreased mobility, decreased blood flow, and thinning skin.

Pressure ulcers can be classified into several different stages based on their severity and the extent of tissue damage. Treatment for pressure ulcers typically involves addressing the underlying cause and providing wound care to promote healing. This may include changing positions frequently, using support surfaces to reduce pressure, and managing incontinence and moisture. In severe cases, surgery may be necessary to clean and close the wound.

Prevention is key in avoiding pressure ulcers. Strategies for prevention include:

1. Turning and repositioning frequently to redistribute pressure.
2. Using support surfaces that are designed to reduce pressure on the skin, such as foam mattresses or specialized cushions.
3. Maintaining good hygiene and keeping the skin clean and dry.
4. Managing incontinence and moisture to prevent skin irritation and breakdown.
5. Monitoring nutrition and hydration to ensure adequate intake.
6. Encouraging mobility and physical activity to improve circulation and reduce immobility.
7. Avoiding tight clothing and bedding that can constrict the skin.
8. Providing proper skin care and using topical creams or ointments to prevent skin breakdown.

In conclusion, pressure ulcers are a common complication of immobility and can lead to significant morbidity and mortality. Understanding the causes and risk factors for pressure ulcers is essential in preventing and managing these wounds. Proper assessment, prevention, and treatment strategies can improve outcomes and reduce the burden of pressure ulcers on patients and healthcare systems.

Types of Skin Ulcers:

1. Pressure ulcers (bedsores): These occur when pressure is applied to a specific area of the skin for a long time, causing the skin to break down. They are more common in people who are bedridden or have mobility issues.
2. Diabetic foot ulcers: These are caused by nerve damage and poor circulation in people with diabetes, which can lead to unnoticed injuries or infections that do not heal properly.
3. Venous ulcers: These occur when the veins have difficulty returning blood to the heart, causing pressure to build up in the legs and feet. This pressure can cause skin breakdown and ulceration.
4. Arterial ulcers: These are caused by poor circulation due to blockages or narrowing of the arteries, which can lead to a lack of oxygen and nutrients to the skin.
5. Traumatic ulcers: These are caused by injuries or surgery and can be shallow or deep.

Symptoms of Skin Ulcers:

1. Pain
2. Redness around the wound
3. Swelling
4. Discharge or pus
5. A foul odor
6. Increased pain when touched or pressure is applied
7. Thick, yellowish discharge
8. Skin that feels cool to the touch
9. Redness that spreads beyond the wound margins
10. Fever and chills

Treatment for Skin Ulcers:

1. Debridement: Removing dead tissue and bacteria from the wound to promote healing.
2. Dressing changes: Applying a dressing that absorbs moisture, protects the wound, and promotes healing.
3. Infection control: Administering antibiotics to treat infections and prevent further complications.
4. Pain management: Managing pain with medication or other interventions.
5. Offloading pressure: Reducing pressure on the wound using specialized mattresses, seat cushions, or orthotics.
6. Wound cleansing: Cleaning the wound with saline solution or antimicrobial agents to remove bacteria and promote healing.
7. Nutritional support: Providing adequate nutrition to promote wound healing.
8. Monitoring for signs of infection: Checking for signs of infection, such as increased redness, swelling, or drainage, and addressing them promptly.
9. Addressing underlying causes: Managing underlying conditions, such as diabetes or poor circulation, to promote wound healing.
10. Surgical intervention: In some cases, surgery may be necessary to promote wound healing or repair damaged tissue.

Prevention of pressure sores is always preferable to treatment, and this can be achieved by taking steps such as:

1. Turning and repositioning regularly: Changing positions regularly, at least every two hours, to redistribute pressure.
2. Using pressure-relieving support surfaces: Using mattresses or cushions that reduce pressure on the skin.
3. Keeping the skin clean and dry: Ensuring the skin is clean and dry, especially after incontinence or sweating.
4. Monitoring nutrition and hydration: Ensuring adequate nutrition and hydration to support healing.
5. Managing underlying conditions: Managing conditions such as diabetes, poor circulation, or immobility to reduce the risk of pressure sores.
6. Using barrier creams or films: Applying barrier creams or films to protect the skin from moisture and friction.
7. Providing adequate cushioning: Using cushions or pillows that provide adequate support and reduce pressure on the skin.
8. Encouraging mobility: Encouraging regular movement and exercise to improve circulation and reduce immobility.
9. Monitoring for signs of pressure sores: Regularly checking for signs of pressure sores, such as redness, swelling, or pain.
10. Seeking medical advice if necessary: Seeking medical advice if pressure sores are suspected or if there are any concerns about their prevention or treatment.

* Definition of Dumping Syndrome
* Causes and Risk Factors
* Symptoms
* Diagnosis
* Treatment Options

Definition:

Dumping syndrome is a condition that occurs when food, especially sugar-rich or high-carbohydrate meals, moves too quickly from the stomach into the small intestine, causing symptoms such as dizziness, lightheadedness, nausea, vomiting, diarrhea, and abdominal cramps.

Causes and Risk Factors:

Dumping syndrome can occur after eating a meal that is high in sugar or carbohydrates, particularly if it is consumed quickly or in large quantities. Other risk factors for dumping syndrome include:

* Gastrointestinal surgery, such as gastric bypass surgery or surgical removal of part of the small intestine
* Certain medical conditions, such as diabetes, thyroid disorders, and pancreatic insufficiency
* Pregnancy
* Poor eating habits, such as eating on the go or not chewing food properly

Symptoms:

The symptoms of dumping syndrome typically occur within 30 minutes to an hour after eating and may include:

* Dizziness or lightheadedness
* Nausea and vomiting
* Diarrhea
* Abdominal cramps
* Headache
* Fatigue

Diagnosis:

Dumping syndrome can be diagnosed based on a patient's symptoms, medical history, and the results of certain tests, such as:

* Blood tests to check for low blood sugar or other hormone imbalances
* Endoscopy or upper GI series to visualize the stomach and small intestine
* Hydrogen breath test to measure the amount of sugar in the breath

Treatment Options:

Treatment for dumping syndrome typically focuses on managing symptoms and making changes to diet and lifestyle. Treatment options may include:

* Avoiding high-carbohydrate, low-fiber foods that can cause a rapid increase in blood sugar
* Eating smaller, more frequent meals throughout the day to prevent large spikes in blood sugar
* Avoiding alcohol and caffeine, which can worsen symptoms
* Drinking plenty of water to stay hydrated
* Probiotics to improve gut health
* Medications to manage symptoms such as nausea and vomiting

In some cases, surgery may be necessary to treat underlying conditions such as gastric bypass surgery or other digestive disorders.

Managing Dumping Syndrome:

Dumping syndrome can be managed with the right diet and lifestyle changes. Here are some tips for managing the condition:

* Eat small, frequent meals throughout the day to prevent large spikes in blood sugar
* Avoid high-carbohydrate, low-fiber foods that can cause rapid increases in blood sugar
* Drink plenty of water to stay hydrated
* Incorporate probiotics into your diet to improve gut health
* Avoid alcohol and caffeine, which can worsen symptoms
* Exercise regularly to help manage symptoms
* Monitor your blood sugar levels regularly to ensure that they are within a healthy range.

In conclusion, dumping syndrome is a common complication of gastric bypass surgery and other digestive disorders. It can cause a range of uncomfortable symptoms, including diarrhea, nausea, vomiting, dizziness, and fainting. To manage the condition effectively, it's important to work with a healthcare provider to develop a personalized treatment plan that addresses your specific needs and symptoms. With the right diet, lifestyle changes, and medical treatment, it's possible to manage dumping syndrome and improve your overall quality of life.

Symptoms of gastritis may include abdominal pain, nausea, vomiting, loss of appetite, and difficulty swallowing. In severe cases, bleeding may occur in the stomach and black tarry stools may be present.

Diagnosis of gastritis is typically made through endoscopy, during which a flexible tube with a camera and light on the end is inserted through the mouth to visualize the inside of the stomach. Biopsies may also be taken during this procedure to examine the stomach tissue under a microscope for signs of inflammation or infection.

Treatment of gastritis depends on the underlying cause, but may include antibiotics for bacterial infections, anti-inflammatory medications, and lifestyle modifications such as avoiding alcohol, losing weight, and eating smaller more frequent meals. In severe cases, surgery may be necessary to remove damaged tissue or repair any ulcers that have developed.

Dyspepsia is not a specific disease but rather a symptom complex that can be caused by a variety of factors, such as:

1. Gastritis (inflammation of the stomach lining)
2. Peptic ulcer
3. Gastroesophageal reflux disease (GERD)
4. Functional dyspepsia
5. Inflammatory conditions such as Crohn's disease or ulcerative colitis
6. Food allergies or intolerances
7. Hormonal changes during pregnancy or menstruation
8. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics

The diagnosis of dyspepsia is based on a combination of medical history, physical examination, and diagnostic tests such as endoscopy, gastric emptying studies, and blood tests. Treatment depends on the underlying cause of dyspepsia and may include medications, lifestyle changes, and dietary modifications.

In medical terminology, "itis" is a suffix that indicates inflammation or infection. Therefore, duodenitis specifically refers to the inflammation of the duodenum.

Examples of medical conditions that may cause duodenitis include:

* Viral or bacterial infections
* Autoimmune disorders such as Crohn's disease or ulcerative colitis
* Gut injury due to trauma, surgery, or burns
* Radiation therapy or chemotherapy

Duodenitis can be diagnosed through various medical tests such as:

* Endoscopy: A flexible tube with a camera and light on the end is inserted through the mouth and into the duodenum to visualize the inside of the digestive tract.
* Biopsy: A small sample of tissue is taken from the duodenum for examination under a microscope.
* Blood tests: To check for signs of infection or inflammation, such as elevated white blood cell count or liver enzymes.

Treatment options for duodenitis depend on the underlying cause and severity of the condition. Some possible treatment options include:

* Antibiotics to treat bacterial infections
* Anti-inflammatory medications such as corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain.
* Dietary modifications, such as avoiding trigger foods or taking probiotics to promote gut health.
* Stress management techniques, such as relaxation exercises or cognitive behavioral therapy, to help manage symptoms of stress-related duodenitis.
* Surgery may be necessary in severe cases or if other treatments are not effective.

It is important to seek medical attention if you experience persistent or severe abdominal pain, as duodenitis can be a sign of a more serious underlying condition. A healthcare professional can help determine the cause and develop an appropriate treatment plan.

Recurrence can also refer to the re-emergence of symptoms in a previously treated condition, such as a chronic pain condition that returns after a period of remission.

In medical research, recurrence is often studied to understand the underlying causes of disease progression and to develop new treatments and interventions to prevent or delay its return.

Buruli ulcer is most commonly seen in children and young adults, and the infection is more prevalent in areas with poor sanitation and hygiene. The disease may be acquired through contact with contaminated water or soil, or through direct skin-to-skin contact with an infected person.

The symptoms of Buruli ulcer can vary in severity and may include:

* Painless ulcers or nodules on the skin
* Swelling and redness around the affected area
* Fever
* Fatigue
* Loss of mobility or disfigurement if the infection is severe or left untreated

Buruli ulcer can be diagnosed through a combination of clinical examination, laboratory tests, and imaging studies. Treatment typically involves antibiotics and surgical debridement of the affected tissue. In some cases, amputation may be necessary if the infection is severe or has caused significant tissue damage.

Prevention of Buruli ulcer is challenging, but it can be reduced by:

* Improving access to clean water and sanitation
* Practicing good hygiene, such as washing hands regularly
* Avoiding contact with contaminated water or soil
* Seeking medical attention promptly if skin lesions or ulcers develop.

Overall, Buruli ulcer is a debilitating and disfiguring disease that can have significant social and economic impacts on individuals and communities. Early diagnosis and treatment are critical to prevent long-term complications and improve outcomes for those affected.

Symptoms of Zollinger-Ellison syndrome can include abdominal pain, diarrhea, weight loss, and ulcers in the stomach and small intestine. Treatment options for the condition include surgery to remove the tumors, medications to reduce acid production in the stomach, and therapies to manage symptoms such as diarrhea and abdominal pain.

Zollinger-Ellison syndrome is a rare disorder that affects approximately 1 in 50,000 to 1 in 100,000 people worldwide. It can occur at any age but is most commonly diagnosed in adults between the ages of 30 and 60 years old. The condition is more common in women than in men.

The exact cause of Zollinger-Ellison syndrome is not fully understood, but it is believed to be related to genetic mutations that occur in the tumors. In some cases, the condition may be inherited from a parent. Other risk factors for developing Zollinger-Ellison syndrome include having a family history of the condition, having other endocrine tumors, or taking certain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or proton pump inhibitors (PPIs).

Overall, Zollinger-Ellison syndrome is a rare and complex condition that requires specialized medical care to diagnose and treat. With appropriate treatment, many people with the condition can experience significant improvement in symptoms and quality of life.

Some common examples of duodenal diseases include:

1. Peptic ulcers: These are open sores that develop in the lining of the duodenum and can be caused by infection with Helicobacter pylori bacteria or the use of nonsteroidal anti-inflammatory drugs (NSAIDs).
2. Duodenal cancer: This is a rare type of cancer that develops in the lining of the duodenum. It can be treated with surgery, chemotherapy, and radiation therapy.
3. Inflammatory bowel disease (IBD): This is a chronic condition that causes inflammation in the digestive tract, including the duodenum. Symptoms of IBD include abdominal pain, diarrhea, and weight loss.
4. Duodenal webs or rings: These are congenital abnormalities that can cause blockages or narrowing in the duodenum.
5. Pancreatitis: This is inflammation of the pancreas, which can spread to the duodenum and cause damage to the lining of the duodenum.
6. Gastrointestinal hormone deficiency: This is a condition where the body does not produce enough gastrointestinal hormones, which can lead to symptoms such as diarrhea, abdominal pain, and weight loss.
7. Duodenal polyps: These are growths that develop in the lining of the duodenum and can be benign or cancerous.
8. Duodenal obstruction: This is a blockage that develops in the duodenum and can be caused by a variety of factors, including tumors, adhesions, and inflammation.

Duodenal diseases can be diagnosed through a range of tests, including:

1. Endoscopy: This is a procedure where a flexible tube with a camera and light on the end is inserted into the duodenum to visualize the inside of the duodenum and collect tissue samples.
2. Biopsy: This is a procedure where a small sample of tissue is removed from the duodenum and examined under a microscope for signs of disease.
3. CT scan or MRI: These are imaging tests that use X-rays or magnetic fields to produce detailed images of the duodenum and surrounding tissues.
4. Blood tests: These can be used to check for signs of infection, inflammation, or other conditions affecting the duodenum.
5. Stool tests: These can be used to check for signs of infection or inflammation in the duodenum.

Treatment for duodenal diseases will depend on the specific condition and its cause, but may include:

1. Medications: Such as antibiotics, anti-inflammatory drugs, and acid-suppressing medications to manage symptoms and reduce inflammation.
2. Lifestyle changes: Such as avoiding trigger foods, eating smaller meals, and managing stress.
3. Endoscopy: To remove any blockages or abnormal growths in the duodenum.
4. Surgery: In some cases, surgery may be necessary to repair damaged tissue or remove affected tissue.
5. Nutritional support: To ensure that the patient is getting enough nutrients and electrolytes.

It's important to note that a proper diagnosis from a medical professional is essential for effective treatment of duodenal diseases.

There are many different types of stomach diseases, some of which include:

1. Gastritis: This is inflammation of the stomach lining, which can be caused by infection, autoimmune disorders, or excessive alcohol consumption.
2. Peptic ulcer: This is a sore on the lining of the stomach or duodenum (the first part of the small intestine). Peptic ulcers are often caused by infection with the bacterium Helicobacter pylori, but they can also be caused by excessive acid production.
3. Gastroesophageal reflux disease (GERD): This is a condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn and difficulty swallowing.
4. Stomach cancer: This is a type of cancer that affects the stomach lining, and it can be caused by a variety of factors including age, diet, and family history.
5. Inflammatory bowel disease (IBD): This is a chronic condition that causes inflammation in the digestive tract, including the stomach. Crohn's disease and ulcerative colitis are examples of IBD.
6. Gastrointestinal motility disorders: These are conditions that affect the muscles and nerves of the digestive system, causing problems with movement and contraction of the stomach and intestines.
7. Stomach polyps: These are growths on the lining of the stomach that can be benign or cancerous.
8. Hiatal hernia: This is a condition in which part of the stomach bulges up into the chest through a hole in the diaphragm, which can cause symptoms such as heartburn and difficulty swallowing.
9. Gastroesophageal reflux disease (GERD): This is a chronic form of acid reflux that can cause symptoms such as heartburn and difficulty swallowing.
10. Zollinger-Ellison syndrome: This is a rare condition that causes the stomach to produce too much acid, leading to symptoms such as heartburn, nausea, and vomiting.

These are just some of the many possible causes of stomach pain. It's important to see a doctor if you experience persistent or severe stomach pain, especially if it is accompanied by other symptoms such as fever, bleeding, or difficulty swallowing. Your doctor can perform tests and examinations to determine the cause of your stomach pain and recommend appropriate treatment.

The severity of GIH can vary widely, ranging from mild to life-threatening. Mild cases may resolve on their own or with minimal treatment, while severe cases may require urgent medical attention and aggressive intervention.

Gastrointestinal Hemorrhage Symptoms:

* Vomiting blood or passing black tarry stools
* Hematemesis (vomiting blood)
* Melena (passing black, tarry stools)
* Rectal bleeding
* Abdominal pain
* Fever
* Weakness and dizziness

Gastrointestinal Hemorrhage Causes:

* Peptic ulcers
* Gastroesophageal reflux disease (GERD)
* Inflammatory bowel disease (IBD)
* Diverticulosis and diverticulitis
* Cancer of the stomach, small intestine, or large intestine
* Vascular malformations

Gastrointestinal Hemorrhage Diagnosis:

* Physical examination
* Medical history
* Laboratory tests (such as complete blood count and coagulation studies)
* Endoscopy (to visualize the inside of the gastrointestinal tract)
* Imaging studies (such as X-rays, CT scans, or MRI)

Gastrointestinal Hemorrhage Treatment:

* Medications to control bleeding and reduce acid production in the stomach
* Endoscopy to locate and treat the site of bleeding
* Surgery to repair damaged blood vessels or remove a bleeding tumor
* Blood transfusions to replace lost blood

Gastrointestinal Hemorrhage Prevention:

* Avoiding alcohol and spicy foods
* Taking medications as directed to control acid reflux and other gastrointestinal conditions
* Maintaining a healthy diet and lifestyle
* Reducing stress
* Avoiding smoking and excessive caffeine consumption.

1. Peptic ulcers: These are open sores that develop on the lining of the stomach or duodenum (the first part of the small intestine). Peptic ulcers can cause bleeding, which may lead to hematemesis.
2. Esophageal varices: These are enlarged veins in the esophagus that can rupture and cause bleeding. This condition is often seen in people with liver cirrhosis or other liver diseases.
3. Gastrointestinal (GI) tumors: Tumors in the GI tract, such as stomach cancer or colon cancer, can cause bleeding that leads to hematemesis.
4. Mallory-Weiss syndrome: This is a condition in which the esophagus and stomach are injured due to violent vomiting, leading to bleeding.
5. Inflammatory conditions: Conditions such as gastritis or inflammatory bowel disease (IBD) can cause bleeding in the GI tract, leading to hematemesis.
6. Medications: Certain medications, such as aspirin or warfarin, can thin the blood and increase the risk of bleeding.
7. Trauma: Injuries to the head, neck, or torso can cause internal bleeding that may lead to hematemesis.
8. Radiation therapy: Radiation therapy to the chest or abdomen can damage the GI tract and cause bleeding.
9. Gastrointestinal angiodysplasia: This is a rare condition in which abnormal blood vessels in the GI tract cause bleeding.

Symptoms of hematemesis may include vomiting blood, which may be bright red or have a coffee ground consistency, depending on the location of the bleeding. Other symptoms may include abdominal pain, weakness, and dizziness. Treatment for hematemesis will depend on the underlying cause, but may include medications to stop bleeding, endoscopy to locate the source of the bleeding, or surgery if necessary.

There are several types of stomach neoplasms, including:

1. Adenocarcinoma: This is the most common type of stomach cancer, accounting for approximately 90% of all cases. It begins in the glandular cells that line the stomach and can spread to other parts of the body.
2. Squamous cell carcinoma: This type of cancer begins in the squamous cells that cover the outer layer of the stomach. It is less common than adenocarcinoma but more likely to be found in the upper part of the stomach.
3. Gastric mixed adenocarcinomasquamous cell carcinoma: This type of cancer is a combination of adenocarcinoma and squamous cell carcinoma.
4. Lymphoma: This is a cancer of the immune system that can occur in the stomach. It is less common than other types of stomach cancer but can be more aggressive.
5. Carcinomas of the stomach: These are malignant tumors that arise from the epithelial cells lining the stomach. They can be subdivided into adenocarcinoma, squamous cell carcinoma, and others.
6. Gastric brunner's gland adenoma: This is a rare type of benign tumor that arises from the Brunner's glands in the stomach.
7. Gastric polyps: These are growths that occur on the lining of the stomach and can be either benign or malignant.

The symptoms of stomach neoplasms vary depending on the location, size, and type of tumor. Common symptoms include abdominal pain, nausea, vomiting, weight loss, and difficulty swallowing. Diagnosis is usually made through a combination of endoscopy, imaging studies (such as CT or PET scans), and biopsy. Treatment depends on the type and stage of the tumor and may include surgery, chemotherapy, radiation therapy, or a combination of these. The prognosis for stomach neoplasms varies depending on the type and stage of the tumor, but early detection and treatment can improve outcomes.

The symptoms of pyloric stenosis may include:

1. Vomiting, which may be projectile and forceful
2. Abdominal pain, often located in the upper abdomen
3. Dehydration, as vomiting can lead to a loss of fluids and electrolytes
4. Hunger and irritability due to poor feeding
5. Fever

Pyloric stenosis is usually diagnosed through a combination of physical examination, medical history, and diagnostic tests such as an ultrasound or endoscopy. Treatment for pyloric stenosis typically involves surgery to widen the pylorus and allow for easier digestion. In some cases, medications may be used to help manage symptoms until surgery can be performed.

It's important to seek medical attention if you or your child experiences any of these symptoms, as pyloric stenosis can lead to complications such as dehydration and malnutrition if left untreated. With prompt treatment, however, most people with pyloric stenosis can expect a full recovery.

The term "melena" comes from the Greek word for "black," and it is used to describe the characteristic dark color of the stools in these patients. The stools may be black, tarry, and have a distinctive odor, and they may also be accompanied by symptoms such as abdominal pain, nausea, vomiting, and fever.

The diagnosis of melena is typically made through a physical examination and laboratory tests, such as a complete blood count (CBC) and a fecal occult blood test (FOBT). Imaging studies, such as an upper endoscopy or a colonoscopy, may also be performed to identify the site of the bleeding.

Treatment of melena depends on the underlying cause of the bleeding, and it may involve medications, endoscopic therapy, or surgery. In some cases, hospitalization may be necessary to monitor and treat the patient. Prognosis for melena is generally good if the underlying cause is identified and treated promptly, but it can be life-threatening if left untreated.

Types of Gastrointestinal Diseases:

1. Irritable Bowel Syndrome (IBS): A common condition characterized by abdominal pain, bloating, and changes in bowel movements.
2. Inflammatory Bowel Disease (IBD): A group of chronic conditions that cause inflammation in the digestive tract, including Crohn's disease and ulcerative colitis.
3. Gastroesophageal Reflux Disease (GERD): A condition in which stomach acid flows back into the esophagus, causing heartburn and other symptoms.
4. Peptic Ulcer Disease: A condition characterized by ulcers in the lining of the stomach or duodenum.
5. Diverticulitis: A condition in which small pouches form in the wall of the colon and become inflamed.
6. Gastritis: Inflammation of the stomach lining, often caused by infection or excessive alcohol consumption.
7. Esophagitis: Inflammation of the esophagus, often caused by acid reflux or infection.
8. Rectal Bleeding: Hemorrhage from the rectum, which can be a symptom of various conditions such as hemorrhoids, anal fissures, or inflammatory bowel disease.
9. Functional Dyspepsia: A condition characterized by recurring symptoms of epigastric pain, bloating, nausea, and belching.
10. Celiac Disease: An autoimmune disorder that causes the immune system to react to gluten, leading to inflammation and damage in the small intestine.

Causes of Gastrointestinal Diseases:

1. Infection: Viral, bacterial, or parasitic infections can cause gastrointestinal diseases.
2. Autoimmune Disorders: Conditions such as Crohn's disease and ulcerative colitis occur when the immune system mistakenly attacks healthy tissue in the GI tract.
3. Diet: Consuming a diet high in processed foods, sugar, and unhealthy fats can contribute to gastrointestinal diseases.
4. Genetics: Certain genetic factors can increase the risk of developing certain gastrointestinal diseases.
5. Lifestyle Factors: Smoking, excessive alcohol consumption, stress, and lack of physical activity can all contribute to gastrointestinal diseases.
6. Radiation Therapy: Exposure to radiation therapy can damage the GI tract and increase the risk of developing certain gastrointestinal diseases.
7. Medications: Certain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can cause gastrointestinal side effects.

Prevention and Treatment of Diabetic Foot
---------------------------------------

Preventing diabetic foot is crucial for people with diabetes. Here are some steps you can take:

* Monitor your blood sugar levels regularly and work with your healthcare provider to manage them effectively.
* Take care of your feet by washing them daily, trimming your toenails straight across, and wearing properly fitting shoes.
* Get your feet checked regularly by a healthcare professional.
* Avoid smoking and limit alcohol intake.

If you have diabetic foot, treatment will depend on the severity of the condition. Here are some common treatments:

* Antibiotics for infections
* Pain relief medication
* Wound care to promote healing
* Surgery to remove infected tissue or repair damaged blood vessels and nerves
* Amputation as a last resort

It is important to seek medical attention immediately if you have any of the following symptoms:

* Pain or tenderness in your feet
* Redness, swelling, or ulcers on your skin
* Fever or chills
* Difficulty moving your feet or toes

In conclusion, diabetic foot is a serious complication of diabetes that can lead to infections, amputations, and even death. Preventing diabetic foot is crucial for people with diabetes, and early detection and treatment are essential to prevent long-term damage. If you have any concerns about your feet, it is important to seek medical attention immediately.

Examples and Observations:

1. Gastric metaplasia: This is a condition where the stomach lining is replaced by cells that are similar to those found in the esophagus. This can occur as a result of chronic acid reflux, leading to an increased risk of developing esophageal cancer.
2. Bronchial metaplasia: This is a condition where the airways in the lungs are replaced by cells that are similar to those found in the trachea. This can occur as a result of chronic inflammation, leading to an increased risk of developing lung cancer.
3. Pancreatic metaplasia: This is a condition where the pancreas is replaced by cells that are similar to those found in the ducts of the pancreas. This can occur as a result of chronic inflammation, leading to an increased risk of developing pancreatic cancer.
4. Breast metaplasia: This is a condition where the breast tissue is replaced by cells that are similar to those found in the salivary glands. This can occur as a result of chronic inflammation, leading to an increased risk of developing salivary gland cancer.

Etiology and Pathophysiology:

Metaplasia is thought to be caused by chronic inflammation, which can lead to the replacement of one type of cell or tissue with another. This can occur as a result of a variety of factors, including infection, injury, or exposure to carcinogens. Once the metaplastic changes have occurred, there is an increased risk of developing cancer if the underlying cause is not addressed.

Clinical Presentation:

Patients with metaplasia may present with a variety of symptoms, depending on the location and extent of the condition. These can include pain, difficulty swallowing or breathing, coughing up blood, and weight loss. In some cases, patients may be asymptomatic and the condition may be detected incidentally during diagnostic testing for another condition.

Diagnosis:

The diagnosis of metaplasia is typically made based on a combination of clinical findings, radiologic imaging (such as CT scans or endoscopies), and histopathological examination of biopsy specimens. Imaging studies can help to identify the location and extent of the metaplastic changes, while histopathology can confirm the presence of the metaplastic cells and rule out other potential diagnoses.

Treatment:

Treatment for metaplasia depends on the underlying cause and the severity of the condition. In some cases, treatment may involve addressing the underlying cause, such as removing a tumor or treating an infection. In other cases, treatment may be directed at managing symptoms and preventing complications. This can include medications to reduce inflammation and pain, as well as surgery to remove affected tissue.

Prognosis:

The prognosis for metaplasia varies depending on the underlying cause and the severity of the condition. In general, the prognosis is good for patients with benign metaplastic changes, while those with malignant changes may have a poorer prognosis if the cancer is not treated promptly and effectively.

Complications:

Metaplasia can lead to a number of complications, including:

1. Cancer: Metaplastic changes can sometimes progress to cancer, which can be life-threatening.
2. Obstruction: The growth of metaplastic cells can block the normal functioning of the organ or gland, leading to obstruction and potentially life-threatening complications.
3. Inflammation: Metaplasia can lead to chronic inflammation, which can cause scarring and further damage to the affected tissue.
4. Bleeding: Metaplastic changes can increase the risk of bleeding, particularly if they occur in the digestive tract or other organs.

American Medical Association (2003). "Duodenal Ulcer". In Leiken JS, Lipsky MS (eds.). Complete Medical Encyclopedia (First ed ... peptic ulcers and sexual dysfunction, and can eventually be fatal. Other physical effects include an increased risk of ...
Ulcers can develop as a result of damage caused to the gastric mucosal barrier. Duodenal ulcers have been shown to develop in ... "Duodenal Ulcer". The British Medical Journal. 2 (5456): 291-292. 1965. doi:10.1136/bmj.2.5456.291-a. JSTOR 25403227. PMC ... Because of this, invading agents such as Helicobacter pylori, a bacterium that causes stomach ulcers, can alter the pH of the ...
Gastric and duodenal ulcer. Medical cure by an efficient removal of gastric juice corrosion. (DOI: 10.1001/jama.250.16.2192) ... Sippy, B. W. (October 28, 1983). "Landmark article May 15, 1915: Gastric and duodenal ulcer. Medical cure by an efficient ... He was most notable for his pioneering treatment for peptic ulcer disease; linking the acidity of the stomach to the severity ... This treatment revolutionized the healing of the ulcers, but was ultimately superseded due to its inability to prevent their ...
Kasich AM, Fein HD (January 1958). "Hexocyclium methosulfate in active duodenal ulcer; evaluation of a new anticholinergic drug ...
The cause of death was shown as: (a) Septicaemia; (b) Haemorhage (c) Chronic duodenal Ulcer. His papers are in the Senate House ...
Rauws, E.A.J.; G.N.J. Tytgat (1990). "Cure of duodenal ulcer associated with eradication of Helicobacter pylori". The Lancet. ... Rauws and Tytgat describe cure of duodenal ulcer by eradication of H. pylori using Borody's triple therapy combination. Triple- ... World Congress of Gastroenterology recommends eradicating H. pylori to cure duodenal ulcers. First report of resistance of H. ... 1987). "Campylobacter pylori and recurrence of duodenal ulcers-a 12-month follow-up study". The Lancet. 2 (8568): 109-11. doi: ...
He developed a new surgical procedure (surgical vagotomy) for duodenal ulcers (resulting from peptic ulcer disease). He was a ... Gastric juice in duodenal and gastric ulcers. J. Am. Med. Assoc, 68:330-33. With J. J. Moorhead and F. W. Burcky. An ... 1962 Section of the vagus nerves to the stomach in the treatment of duodenal ulcer. In: Surgery of the Stomach and Duodenum, ed ... Direct observations on the mechanism of pain in duodenal ulcer. Proc. Soc. Exp. Biol. Med., 29:753-55. With W. B. Matthews. The ...
An ulcer in the stomach is called a gastric ulcer, while one in the first part of the intestines is a duodenal ulcer. The most ... Duodenum (called duodenal ulcer) Esophagus (called esophageal ulcer) Stomach (called gastric ulcer) Meckel's diverticulum ( ... Type II: Ulcer in the body in combination with duodenal ulcers. Associated with acid oversecretion. Type III: In the pyloric ... An acidic environment at the antrum causes metaplasia of the duodenal cells, causing duodenal ulcers. Human immune response ...
He died from a burst duodenal ulcer. The inquest was opened by Dr. F. W. Hardman on 26 September and went on to 24 October. ...
April 1981). "[Duodenal ulcer - multicenter double-blind study with proglumide]". Medizinische Klinik. 76 (8): 226-9. PMID ... It was used mainly in the treatment of stomach ulcers, although it has now been largely replaced by newer drugs for this ... Tariq M, Parmar NS, Ageel AM (May 1987). "Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats". The ...
R. E. Pounder; J. G. Williams; G. J. Milton-Thompson; J. J. Misiewicz (10 May 1975). "Relief of Duodenal Ulcer Symptoms By Oral ... Pounder R (1975). "24-Hour Control of Intragastric Acidity by Cimetidine in Duodenal-Ulcer Patients". The Lancet. 306 (7944): ... and demonstrating efficacy in duodenal ulcer disease, a common cause of significant morbidity in sailors. In 1982, he led a ... "Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide". Lancet. 1 (7860): 693-4. doi:10.1016/ ...
Avoidance behavior and the development of duodenal ulcers. Journal of the Experimental Analysis of Behavior, 1(1), 69-72. doi: ... In all the variations of the experiment, no yoked control monkey ever developed an ulcer. This suggests that the ulcers were a ... Ulcers in Executive Monkeys was a study into the effects of stress, published in 1958 in Scientific American by Joseph V. Brady ... This study came to an abrupt halt when many of the monkeys died from perforated ulcers. To test this Brady used a yoked control ...
It delays healing of gastric and duodenal ulcers." Sir Robert Platt, the president of the organization, led a committee of nine ...
Walton died of a duodenal ulcer, aged 57. George Walton, the son of Joseph Walton, served as headmaster from 1912 to 1948, the ...
Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB (September 1982). "Immediate definitive surgery for perforated duodenal ulcers: a ... Truncal vagotomy is a treatment option for chronic duodenal ulcers. It was once considered the gold standard, but is now ... Vagotomy is an essential component of surgical management of peptic (duodenal and gastric) ulcer disease (PUD). Vagotomy was ... The preferred operation for perforations in acute duodenal ulcer". Annals of Surgery. 208 (2): 169-74. doi:10.1097/00000658- ...
In 1925, Kuhn almost died from a duodenal ulcer. Following an arduous recovery, he became an instructor at the Art Students ... In 1948, he was institutionalized, and on July 13, 1949, he died suddenly from a perforated ulcer. He is interred in Woodlawn ... Deaths from ulcers, 19th-century American painters, 19th-century American male artists, American male painters, 20th-century ...
Kopp, M. S.; Korányi, L (1982). "Autonomic and psychologic correlates in hypertension and duodenal ulcer". The Pavlovian ...
Nesbit died in 1927 of a perforated duodenal ulcer. Loughlin, Graham (1988). "Nesbit, Paris (1852-1927)". Australian Dictionary ...
Inflammation of the pyloric antrum, which connects the stomach to the duodenum, is more likely to lead to duodenal ulcers, ... In 1994, the National Institutes of Health stated most recurrent duodenal and gastric ulcers were caused by H. pylori, and ... About 10-20% of those colonized by H. pylori ultimately develop gastric and duodenal ulcers. H. pylori infection is also ... Acquisition at an older age brings different gastric changes more likely to lead to duodenal ulcer. Infections are usually ...
Box, C. R. (1912). "Left-Sided Subphrenic Abscess Due to Perforated Duodenal Ulcer". British Medical Journal. 1 (2677): 889-890 ...
Patients with active duodenal or gastric ulcers and those with a prior ulcer history should be tested for H. pylori. ... "Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication". Medical Journal of Australia. 151 (8): 431- ... Helicobacter pylori eradication protocols is a standard name for all treatment protocols for peptic ulcers and gastritis in the ... Sonnenberg, A (June 2007). "Time trends of ulcer mortality in Europe". Gastroenterology. 132 (7): 2320-7. doi:10.1053/j.gastro. ...
Duggan died from a duodenal ulcer in 1934 at Moreland. Louis, L. J. (1981). "Duggan, William Joseph (1884-1934)". Australian ...
Brooke, Eileen M. (1950). "Relative Incidence Of Gastric And Duodenal Ulcers". The British Medical Journal. 2 (4678): 560-561. ... and gastric ulcers. She was elected a fellow of the Royal Statistical Society in 1943. In the 1950s, Brooke was a statistician ...
Endorphin-containing cells in the gastric antral mucosa in duodenal ulcer]". Biulleten' Eksperimental'noi Biologii I Meditsiny ...
Morgan had throughout his life suffered with a chronic duodenal ulcer. In 1945, at age 79, he experienced a severe heart attack ...
It has launched in Korea and China for the treatment of gastric ulcer, duodenal ulcer, gastroesophageal reflux disease and ... Ji XQ, Du JF, Chen G, Chen G, Yu B (May 2014). "Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis". ... Bohidar NP, Krishna K, Panda BK, Patel C (2013). "Ilaprazole: Is this a superior proton pump inhibitor for duodenal ulcer?". ... Clinical trial number NCT00952978 for "Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)" at ...
Belohlavek D, Malfertheiner P (1979). "The effect of zolimidine, imidazopyridine-derivate, on the duodenal ulcer healing". ... Drugs used for peptic ulcer disease (PUD), GERD and gastroprokinetic agents (motility stimulants): Imidazo[1,2-a]pyridines: CJ- ...
Relief of heartburn, acid indigestion, and sour stomach Treatment for gastric and duodenal ulcers Treatment for pathologic ... ibuprofen alone for reduction of gastric and duodenal ulcers". The American Journal of Gastroenterology. 107 (3): 379-86. doi: ... Efficacy of different schemes of anti-helicobacter therapy in duodenal ulcer]". Terapevticheskii Arkhiv. 76 (2): 18-22. PMID ... It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is taken by mouth ...
Forgan Smith suffered from duodenal ulcers for much of his life. In the early 1940s, his bronchial condition was diagnosed as ...
Belohlavek, D; Malfertheiner, P (1979). "The Effect of Zolimidine, Imidazopyridine-derivate, on the Duodenal Ulcer Healing". ... Zolimidine (zoliridine, brand name Solimidin) is a gastroprotective drug previously used for peptic ulcer and gastroesophageal ...
Following brief military service in Korea (he was discharged due to a duodenal ulcer he had suffered since childhood), he ...
"Diagnosis of Chronic Duodenal and Gastric Ulcers," on how to recognize ulcers adeptly. As Snell was the doctor in charge of the ... Snell, John A. (July 1918). "The Diagnosis of Chronic Duodenal and Gastric Ulcers" (PDF). The China Medical Journal. 32 (4). ... Snell insisted that gastric ulcers were far more common among Chinese patients than previously believed, and that many cases of ... X-ray and associated equipment, he devised a technique to detect ulcers via X-ray analysis through the consumption of barium- ...
He died in March 1933 following a surgical operation on a duodenal ulcer after which he also contracted pneumonia. In order to ...
Despite being rejected by army due to a duodenal ulcer, Gahan applied a second time, only be to turned away again. This ...
Initially turned down for military service owing to a duodenal ulcer, Gray later managed to enlist in the Gordon Highlanders, ...
Active duodenal ulcer not related to NSAID use Maintenance therapy for resolved duodenal ulcers Gastric ulcer not related to ... Sucralfate is used for the treatment of active duodenal ulcers not related to the use of nonsteroidal anti-inflammatory drugs ( ... Stress ulcer prophylaxis-The use of sucralfate rather than H2 antagonists for stress ulcer prophylaxis, and measures to prevent ... The use for sucralfate in peptic ulcer disease has diminished recently, but it is still the preferred agent for stress ulcer ...
Adjustable gastric band Duodenal switch surgery StomaphyX-Revisional, natural orifice procedure for patients that have regained ... Possible causes of such ulcers are: Restricted blood supply to the anastomosis (compared to the blood supply available to the ... It involves the implantation of a duodenal-jejunal bypass liner between the beginning of the duodenum (first portion of the ... Today thousands of "loops" are used for surgical procedures to treat gastric problems such as ulcers, stomach cancer, and ...
Trobec then complained of a duodenal ulcer and issues with his kidneys, due to which his attorney requested that his medical ...
Gastric ulcer Gastric cancer Gastritis Gastric varices Gastric antral vascular ectasia Dieulafoy's lesions Duodenal causes: ... Duodenal ulcer Vascular malformation, including aorto-enteric fistulae. Fistulae are usually secondary to prior vascular ... Upper gastrointestinal bleeding can be caused by peptic ulcers, gastric erosions, esophageal varices, and rarer causes such as ... Esophageal varices Esophagitis Esophageal cancer Esophageal ulcers Mallory-Weiss tear Gastric causes: ...
... tour started but was curtailed after Marriott damaged his hand and shortly afterwards suffered from a duodenal ulcer. The band ...
Soon after the colony was transferred to Princeton, in 1935, Brown himself became ill with a duodenal ulcer. Senior colleagues ...
... stomach or duodenal ulcers This collateral radiation is commonly caused by non-targeted delivery (reflux) of the radioactive ... A 2015 NICE review found the main side effect to be bleeding that occurred in about 38% of cases, and radiation-induced ulcer ...
Nkuize M, Gomez-Galdon M, Van Laethem Y, Buset M (2014). "A rare case of hematemesis following gastro-duodenal strongyloides ... Hematemesis may be caused by: Peptic ulcer. This may be related to Zollinger-Ellison syndrome, which causes severe disease. ... It may be caused by ulcers, tumors of the stomach or esophagus, varices, prolonged and vigorous retching, gastroenteritis, ... to treat stomach ulcers if they are present. This is given until endoscopy can be arranged. Blood transfusions may be given if ...
Dr Hutchison had to undergo a gastrojejunostomy at the age of 48 in 1929, for a duodenal ulcer with which he had been suffering ...
1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A ...
... acute appendicitis and giant refractory duodenal ulcer. Peripheral blood eosinophilia and elevated serum IgE are usual but not ...
However, in January, a duodenal ulcer followed by several infections kept her bedridden for weeks, greatly delaying the ...
... thought at that time to be the most important factor in the development of duodenal ulcers. Kay used increasing doses of ... After the war Kay returned to a surgical post at the Western Infirmary, and began research into the cause of peptic ulcer ... histamine to stimulate acid production and found that acid production was higher in patients with duodenal ulcer than in ... It became widely used in the investigation and management of peptic ulcers. His paper describing this test, Effect of Large ...
... skin and soft tissue infections and helicobacter pylori infections associated with duodenal ulcers. Aerobic Gram-positive ...
The ulcer is known initially as a peptic ulcer before the ulcer burns through the full thickness of the stomach or duodenal ... died of perforated duodenal ulcer on 18 January 1936. James Joyce (1882-1941, aged 58) had a perforated ulcer and died on ... A perforated ulcer is a condition in which an untreated ulcer has burned through the mucosal wall in a segment of the ... Perforated peptic ulcer is a serious condition with an overall reported mortality of 5%-25%, rising to as high as 50% with age ...
... including gastric ulcer and duodenal ulcer.[dubious - discuss] https://www.physio-pedia.com/Thermotherapy The fact that the use ...
NOS EBV-positive mucocutaneous ulcer DLBCL associated with chronic inflammation Fibrin-associated diffuse large B-cell lymphoma ... Nodal marginal zone lymphoma Paediatric nodal marginal zone lymphoma Follicular lymphoma In situ follicular neoplasia Duodenal- ...
When a peptic ulcer bursts, the gastrointestinal or duodenal fluid leaks through it and pools in the right paracolic gutter ... In medicine, Valentino's syndrome is pain presenting in the right lower quadrant of the abdomen caused by a duodenal ulcer with ... The cause for Valentino's syndrome is due to a perforated ulcer located in the duodenum. This occurs when ulcers that have gone ... Peptic ulcers are sores or defects that arise from tissue death, that develop in the mucosal lining of the stomach or duodenum ...
... and also stomach or duodenal ulcers. It also contains simethicone, an anti-foaming agent which helps eliminate bloating from ...
HBOT is not only prescribed for patients with wounds, such as diabetic foot ulcers or venous ulcers, but is also an effective ... NWH bariatric surgeons perform duodenal switch and revision surgeries. Screening and preparatory tests prior to surgery include ...
Laser Therapy in the Conditions of Acute Bleeding from Gastric Duodenal Ulcers". In 2013 followed the habilitation work "Acute ... YAG laser therapy in conditions of acute bleeding associated with gastric and duodenal ulcers [Dissertation Summary]. Varna. " ...
Dictionary Definition: duodenal ulcer. duodenal ulcer. An ulcer in the lining of the first part of your small intestine ...
... gastric ulcers account for the rest. Unlike gastric ulcers, which may be malignant in about 5% of cases, duodenal ulcers are ... and these lesions account for two thirds of all peptic ulcers, which are defined as mucosal breaks of 3 mm or greater; ... Duodenal ulcers (DUs) affect nearly 10% of the adult population at some time, ... Images of duodenal ulcers are provided below.). Double-contrast upper gastrointestinal series. Posterior wall duodenal ulcer. ...
Khat chewing is a risk factor of duodenal ulcer  Rajaa, Y.A.; Noman, T.A.; Al Warafi, A.K.; Al Mashraki, N.A.; Al Yosofi, A.M ... Cases of duodenal ulcer admitted to Basra General Hospital for a one-year period prior to economic sanctions were compared with ... Bleeding duodenal ulcer in patients admitted to Erbil City Hospital, Iraq: 1996-2004  ... A study was conducted to test the response to therapy and the relapse rates of endoscopically-confirmed duodenal ulcers. ...
Evaluation of early and late results of radical treatment for perforated duodenal ulcer]. Download Prime PubMed App to iPhone, ... Treatment of perforated duodenal ulcers].. *[Truncal vagotomy with pyloroplasty as a routine procedure in perforated duodenal ... Early results of proximal gastric vagotomy in perforated duodenal ulcer.. *[Perioperative mortality for perforated duodenal and ... 80 and overDuodenal UlcerEvaluation Studies as TopicFemaleGastrectomyGastric MucosaHumansMaleMiddle AgedPeptic Ulcer ...
Copyright © 2023 BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.. ...
Antacid therapy of duodenal ulcer. Effects of smaller doses. Berstad A. Berstad A. Scand J Gastroenterol Suppl. 1982;75:97-9. ... Antacids and anticholinergics in the treatment of duodenal ulcer A Walan. Clin Gastroenterol. 1984 May. ... In doses of not less than 100 mg daily, pirenzepine is a candidate-drug for the short-term treatment of duodenal ulcer. At ... Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Konturek SJ, Kwiecień N ...
... pylori-induced duodenal ulcer disease, and to the relative protection from duodenal ulcer disease that is associated with the ... Trail: Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. This page is ... METHODS: Genomic DNA extracted from the peripheral blood of 69 patients with H. pylori-positive duodenal ulcer disease and 47 H ... Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur Cytokine Netw. ...
32 patients with duodenal ulcer were assigned to receive either 20 mg/day or 60 mg/day omeprazole for 4 weeks. The 2-week ... Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial S Gustavsson, H O Adami, L Lööf, A Nyberg ... Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial S Gustavsson et al. Lancet. 1983. . ... Treatment of duodenal ulcer disease. Clinical results with omeprazole. Walan A. Walan A. Scand J Gastroenterol Suppl. 1986;118: ...
There was a significant increase in smoking among duodenal ulcer patients during sanctions. Other differences between the two ... ABSTRACT Cases of duodenal ulcer admitted to Basra General Hospital for a one-year period prior to economic sanctions were ... Chronic duodenal ulcer (DU) is a major problem of modern society. It is a chronic condition characterized by repeated episodes ... ABSTRACT: Cases of duodenal ulcer admitted to Basra General Hospital for a one-year period prior to economic sanctions were ...
Duodenal Ulcer. In a U.S. multicenter, double-blind study in outpatients with endoscopically confirmed duodenal ulcer, orally ... Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer. Controlled studies in ... multicenter studies of patients with endoscopically confirmed healed duodenal ulcers. In the U.S. study the observed ulcer ... Long-Term Maintenance Treatment of Duodenal Ulcers. Famotidine, 20 mg p.o. h.s. was compared to placebo h.s. as maintenance ...
This is the first pediatric case of isolated duodenal IgG4-RD resulting in duodenal obstruction after multiple ulcers. ... IgG4-related disease of duodenal obstruction due to multiple ulcers in a 12-year-old girl. ... IgG4-related disease of duodenal obstruction due to multiple ulcers in a 12-year-old girl. ... Gastroscopy revealed duodenal stenosis and ulceration. Computed tomography revealed edematous duodenal wall thickening and air- ...
14.1 Active Duodenal Ulcer 14.2 Active Gastric Ulcer 14.3 Symptomatic Gastroesophageal Reflux Disease (GERD) 14.4 Erosive ... Table 4: Patients with Endoscopically Confirmed Healed Duodenal Ulcers Famotidine Tablets 40 mg at bedtime. (N=89) Famotidine ... duodenal ulcer, gastric ulcer) and GERD (i.e., symptomatic nonerosive GERD, erosive esophagitis as diagnosed by endoscopy). The ... Active duodenal ulcer (DU) 40 mg once daily; or 20 mg twice dailya Up to 8 weeksb,c ...
Start Over You searched for: Subjects Duodenal Ulcer -- complications ✖Remove constraint Subjects: Duodenal Ulcer -- ... A fatal case of latent perforating ulcer of the duodenum (at the gastro duodenal junction) ... A fatal case of latent perforating ulcer of the duodenum (at the gastro duodenal junction)1 ...
2. Duodenal ulcer. The symptomatology of this ulcer, occurring in the wall of the first part of the small intestine, into which ... Peptic Ulcer. Dr Swami Karmananda Saraswati, MB, BS (Syd.). Peptic ulcer is a small hole burned into the wall of the stomach or ... Medical science recognises two distinct types of peptic ulcer - gastric and duodenal - depending on the site in which it ... Management of ulcer. Obviously the ulcer sufferer finds himself in a mess from which he knows not how to escape. Medical ...
"Closure of Perforated Duodenal Ulcer." Zollingers Atlas of Surgical Operations, 11e Ellison E, Zollinger, Jr. RM, Pawlik TM, ... Closure of Perforated Duodenal Ulcer. In: Ellison E, Zollinger, Jr. RM, Pawlik TM, Vaccaro PS, Bitans M, Baker AS. Ellison E ... Closure of perforated duodenal ulcer. Ellison E, Zollinger, Jr. RM, Pawlik TM, Vaccaro PS, Bitans M, Baker AS. Ellison E, & ... Perforation of an ulcer of the stomach or duodenum is a surgical emergency, but before performing the operation, sufficient ...
A peptic ulcer is an open sore or raw area in the lining of the stomach or intestine. ... Ulcer - peptic; Ulcer - duodenal; Ulcer - gastric; Duodenal ulcer; Gastric ulcer; Dyspepsia - ulcers; Bleeding ulcer; ... peptic ulcer; G.I. bleed - peptic ulcer; H. pylori - peptic ulcer; Helicobacter pylori - peptic ulcer ... Small ulcers may not cause any symptoms and may heal without treatment. Some ulcers can cause serious bleeding. ...
Percutaneous Treatment of an Intrahepatic Abscess Caused by a Penetrating Duodenal Ulcer. Taylor, Kenneth J.; Allard, Jeffrey C ...
Duodenal Ulcer Perforation † 0/950 (0.00%) 1/934 (0.11%) Dysphagia † 1/950 (0.11%) 0/934 (0.00%) ...
Gastric ulcer. 26 (8.0). Duodenal erosion. 24 (7.0). Barrett esophagus. 9 (3.0). ...
April 1981). "[Duodenal ulcer - multicenter double-blind study with proglumide]". Medizinische Klinik. 76 (8): 226-229. PMID ... Tariq M, Parmar NS, Ageel AM (May 1987). "Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats". The ... It was used mainly in the treatment of stomach ulcers,[3][4] although it has now been largely replaced by newer drugs for this ...
vacA genotypes in Helicobacter pylori strains isolated from patients with and without duodenal ulcer in Bahrain. Indian Journal ... vacA genotypes in Helicobacter pylori strains isolated from patients with and without duodenal ulcer in Bahrain. ... All patients with peptic ulcers harbored type s1 strains compared to 75 (82.4%) of 91 patients with non-ulcer dyspepsia (p=0.01 ... Methods One hundred and twenty H. pylori strains were isolated from dyspeptic patients (29 with peptic ulcer, 91 with non-ulcer ...
Arthritis Thyroid problems Esophageal reflux Stomach or duodenal ulcers Respiratory allergies Lower 95% confidence interval (CI ... Stomach or duodenal ulcers. Respiratory allergies. Lower 95% confidence interval (CI). 1.0. 1.3. 1.3. 1.0. 1.4. ...
OR DUODENAL ULCER?" N2AH0509 = "HOW MANY YEARS AGO DID YOU FIRST HAV ..." N2AH0511 = "HAS A DOCTOR EVER TOLD YOU THAT YOU ..." ...
Ever diagnosed with stomach or duodenal ulcer. 502. 259. Ever diagnosed with rheumatoid arthritis or RA. 470. 193. ...
An ulcer. This could be a stomach, duodenal or peptic ulcer. ULCEV. ... Ever Diagnosed with Ulcers Have you EVER been told by a doctor or other health professional that you had … ...
Stomach and Duodenal Ulcer. *In children. *Common Characteristics of Liver Disease. Liver, Biliary, and Pancreatic Diagnostic ...
Peptic ulcer, GERD, esophagitis, heartburn dosing for Nexium, Nexium 24HR (esomeprazole), frequency-based adverse effects, ... Gastric or Duodenal Ulcers Following Therapeutic Endoscopy IV indicated for risk reduction of rebleeding of gastric or duodenal ... Bleeding gastric or duodenal ulcers (IV). *No dosage adjustment required with initial 80 mg/30 min IV dose ... Combination therapy (with amoxicillin and clarithromycin) for eradication of H pylori in patients with duodenal ulcer ...
Peptic Ulcer Disease. 8.1.1. H.pylori, NSAIDs, Zollinger,Ellison syndrome. 8.1.2. Duodenal ulcer ... 8.1.3. Gastic Ulcer. 8.1.3.1. burning epigastric pain made worse by or unrelated to food, anorexia, food aversion, weight loss ... Vesicles, Bullae, Crusted lesions, Folliculitis, Papular and Nodular Lesions,Ulcers with or without eschars, Erysipelas ... fatigue,fever,malaise, weight loss, malar butterfly rash, photosensivity, vasculitis, alopecia, oral ulcers, arthritis, ...
Duodenal Ulcer * Duodenitis * Dyspepsia * Dysphagia * Early Satiety * Elevated Alkaline Phosphatase Level * Elevated Lipase ...
  • BACKGROUND AND AIMS: Helicobacter pylori infection almost invariably causes chronic gastritis, but only a proportion of the infected subjects develop peptic ulcers. (dadamo.com)
  • denal ulcer (19.6%), acute gastritis (12.7%), duo- denitis (10.2%), oesophagitis (7.5%) were the The main limitations of the procedure are its inva- commonest diagnoses. (who.int)
  • There is patients were endoscoped for haematemesis and also the problem of documentation of findings melaena of which chronic duodenal ulcer (32.1%), since the endoscopist may be the only person who gastritis/gastric erosions (12.8%), oesophageal sees the lesion. (who.int)
  • ulcer, gastritis and duodenitis. (who.int)
  • 1. Peptic ulcer and chronic gastritis: their relation to age and sex, and to location of ulcer and gastritis. (nih.gov)
  • 8. [Topography of changes in the mucosa of the gastro-duodenal region in chronic gastritis and peptic ulcer]. (nih.gov)
  • 13. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer]. (nih.gov)
  • 16. Risk of gastroduodenal ulcer in gastritis. (nih.gov)
  • 20. Duodenal ulcer and chronic gastritis. (nih.gov)
  • H. pylori infection is the major cause of chronic gastritis and peptic ulcer[ 3 - 13 ], and is also closely related to adenocarcinoma of stomach and mucosa-associated lymphoid tissue (MALT) lymphoma and primary gastric non-Hodgkin's lymphoma[ 14 - 32 ]. (wjgnet.com)
  • Peptic ulcer disease refers to the clinical presentation and disease state that occurs when there is a disruption in the mucosal surface at the level of the stomach or the first part of the small intestine-the duodenum. (medscape.com)
  • Diagnosis is best made by endoscopy, and in about 90% of patients the ulcer is situated in the first part of the duodenum, within two centimetres of the pylorus [2]. (who.int)
  • Computed tomography revealed edematous duodenal wall thickening and air -fluid levels on the right side of the duodenum , which suggested duodenal perforation or penetration. (bvsalud.org)
  • Peptic ulcer is a small hole burned into the wall of the stomach or duodenum. (yogamag.net)
  • The characteristic gnawing pain of peptic ulcer is produced when the acidic gastric secretions are liberated into the stomach or duodenum and find entry to the ulcer pit, where they cause intense irritation to nerves which lie bare and exposed in the ulcer floor. (yogamag.net)
  • Perforation of an ulcer of the stomach or duodenum is a surgical emergency, but before performing the operation, sufficient time should be allowed for the patient to recover from the initial shock (rarely severe or prolonged) and for restoration of the fluid balance. (mhmedical.com)
  • A peptic ulcer is a sore on the lining of your stomach or the first part of your small intestine (duodenum). (uhhospitals.org)
  • If the ulcer is in your duodenum, it's called a duodenal ulcer. (uhhospitals.org)
  • [ 1 ] Endoscopy has become the diagnostic procedure of choice for patients with suspected duodenal ulcer. (medscape.com)
  • Double-contrast examinations of the upper gastrointestinal tract remain a useful alternative to endoscopy but have lower sensitivity, especially in detection of small duodenal ulcers. (medscape.com)
  • Compared with endoscopy, fluoroscopy is an inexpensive and noninvasive technique that provides salient anatomic information along with delineation of the duodenal mucosa and assessment of real-time duodenal motility. (medscape.com)
  • To detect an ulcer, you may need a test called an upper endoscopy (esophagogastroduodenoscopy or EGD). (medlineplus.gov)
  • thus the place of anticholinergics in the treatment of an active duodenal ulcer is not clear. (nih.gov)
  • active duodenal ulcer (DU). (nih.gov)
  • Medical science recognises two distinct types of peptic ulcer - gastric and duodenal - depending on the site in which it develops. (yogamag.net)
  • The prescription form is used to treat ulcers, GERD, erosive esophagitis, and other conditions. (rxwiki.com)
  • Most duodenal ulcers present with dyspepsia as the primary associated symptom, but presentation can range in severity and may include gastrointestinal bleeding, gastric outlet obstruction, perforation, or fistula development. (medscape.com)
  • A rare but serious complication of peptic ulcer is perforation and haemorrhage. (yogamag.net)
  • The choice for closure of the perforation versus a definitive ulcer procedure depends on the overall assessment of risk factors by the surgeon. (mhmedical.com)
  • Methods One hundred and twenty H. pylori strains were isolated from dyspeptic patients (29 with peptic ulcer, 91 with non-ulcer dyspepsia). (who.int)
  • All patients with peptic ulcers harbored type s1 strains compared to 75 (82.4%) of 91 patients with non-ulcer dyspepsia (p=0.01). (who.int)
  • Duodenal ulcers are part of a broader disease state categorized as peptic ulcer disease. (medscape.com)
  • There is some evidence that long-term treatment with anticholinergic agents can decrease recurrences and complications of peptic ulcer disease. (nih.gov)
  • therefore, this modality is not reliable for detection of duodenitis or duodenal erosions. (medscape.com)
  • The differential diagnosis includes acalculous cholecystitis , acute cholecystitis , cholelithiasis , Crohn disease , gastric ulcer , gastroesophageal reflux , upper gastrointestinal bleeding , acute and chronic pancreatitis , Gastrointestinal tuberculosis , and Zollinger-Ellison syndrome . (medscape.com)
  • Chronic duodenal ulcer (DU) is a major problem of modern society. (who.int)
  • The availability of these facilities also biopsy specimen and 85% in chronic duodenal helps to enhance the teaching of endoscopic skills. (who.int)
  • In the presence of gastric outlet or proximal duodenal obstruction, the endoscope may be unable to pass through the stenosis, and the full extent and the cause of the obstruction may not be defined. (medscape.com)
  • IgG4-related disease of duodenal obstruction due to multiple ulcers in a 12-year-old girl. (bvsalud.org)
  • This is the first pediatric case of isolated duodenal IgG4-RD resulting in duodenal obstruction after multiple ulcers . (bvsalud.org)
  • reduction of the risk of duodenal ulcer recurrence. (nih.gov)
  • The frequency of bleeding duodenal ulcer was assessed in patients admitted with upper gastrointestinal bleeding to Erbil City hospital from the Emergency Department during 1996-2004. (who.int)
  • You have an ulcer without an H pylori infection. (medlineplus.gov)
  • 17. Point prevalence of peptic ulcer and gastric histology in healthy Indians with Helicobacter pylori infection. (nih.gov)
  • Gastric ulcer occurs in the stomach wall. (yogamag.net)
  • Some ulcers can cause serious bleeding. (medlineplus.gov)
  • If a peptic ulcer bleeds a lot, an EGD may be needed to stop the bleeding. (medlineplus.gov)
  • Blood tests can also check for a low blood count if you've had bleeding from the ulcer. (uhhospitals.org)
  • Recurrent ulcer has been mainly observed in patients operated with proximal gastric vagotomy several years after the surgery. (unboundmedicine.com)
  • The most common cause of ulcers is infection of the stomach by bacteria called Helicobacter pylori ( H pylori ). (medlineplus.gov)
  • Most ulcers are caused by an infection from a bacteria or germ called H. pylori. (uhhospitals.org)
  • Often, a mix of antibiotics and other medicines is used to cure the ulcer and get rid of the infection. (uhhospitals.org)
  • IMSEAR at SEARO: vacA genotypes in Helicobacter pylori strains isolated from patients with and without duodenal ulcer in Bahrain. (who.int)
  • The definitive diagnosis of ulcer is made on barium meal X-ray, in which a clearly defined ulcer crater, filled with opaque dye and thus appearing white, is frequently seen either in the gastric or in the duodenal wall. (yogamag.net)
  • 3. Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives. (nih.gov)
  • A rare condition, called Zollinger-Ellison syndrome , causes the stomach to produce too much acid, leading to stomach and duodenal ulcers. (medlineplus.gov)
  • An ulcer in the lining of the first part of your small intestine immediately beyond the stomach. (nih.gov)
  • The symptomatology of this ulcer, occurring in the wall of the first part of the small intestine, into which the gastric contents are emptied via the pyloric valve, are somewhat different. (yogamag.net)
  • A peptic ulcer is an open sore or raw area in the lining of the stomach or intestine. (medlineplus.gov)
  • Surgical treatment of duodenal ulcer. (nih.gov)
  • Death from malignant disease after surgery for duodenal ulcer. (bmj.com)
  • Since such cytokine production is often determined by the genetic polymorphism of regions regulating cytokine gene expression, we investigated the relationship between TNF-alpha and IL-8 polymorphisms and the development of duodenal ulcer disease. (dadamo.com)
  • METHODS: Genomic DNA extracted from the peripheral blood of 69 patients with H. pylori-positive duodenal ulcer disease and 47 H. pylori-positive healthy controls was analyzed for TNF-alpha -308 promoter polymorphism by RFLP, and for IL-8 -251 polymorphism by ARMS. (dadamo.com)
  • This observation draws attention to the possible importance of IL-8 polymorphism as a genetic predisposing factor in the pathomechanism of H. pylori-induced duodenal ulcer disease, and to the relative protection from duodenal ulcer disease that is associated with the TT genotype. (dadamo.com)
  • Treatment of duodenal ulcer disease. (nih.gov)
  • Medical science and yoga are in accordance in recognising that peptic ulcer is a psychosomatic disease, generated as mental stress is relayed into the body's organ systems and physiological mechanisms via the vagus nerve, the parasympathetic limb of the autonomic nervous system. (yogamag.net)
  • The results of the emergency radical treatment of 285 patients with perforated duodenal ulcer are discussed. (unboundmedicine.com)
  • AU - Jarczyk,G, AU - Jedrzejczyk,W, PY - 1996/4/1/pubmed PY - 1996/4/1/medline PY - 1996/4/1/entrez SP - 205 EP - 9 JF - Polski tygodnik lekarski (Warsaw, Poland : 1960) JO - Pol Tyg Lek VL - 51 IS - 14-18 N2 - The results of the emergency radical treatment of 285 patients with perforated duodenal ulcer are discussed. (unboundmedicine.com)
  • In a double-blind, dose-comparative trial, 32 patients with duodenal ulcer were assigned to receive either 20 mg/day or 60 mg/day omeprazole for 4 weeks. (nih.gov)
  • There was a significant increase in smoking among duodenal ulcer patients during sanctions. (who.int)
  • Il y a eu une augmentation importante du tabagisme chez les patients atteints d'ulcère duodénal pendant la période des sanctions. (who.int)
  • In doses of not less than 100 mg daily, pirenzepine is a candidate-drug for the short-term treatment of duodenal ulcer. (nih.gov)
  • The rate of healing of duodenal ulcers during omeprazole treatment. (nih.gov)
  • Treatment will depend on the type of ulcer you have. (uhhospitals.org)
  • It's also linked to ulcers coming back after treatment. (uhhospitals.org)
  • A study was conducted to test the response to therapy and the relapse rates of endoscopically-confirmed duodenal ulcers. (who.int)
  • Your health care provider will recommend medicines to heal your ulcer and prevent a relapse. (medlineplus.gov)
  • After 4 weeks all ulcers but one in the 20 mg/day group were healed (93% healing frequency). (nih.gov)
  • These can occur where the penetrating acid burns its way into a major blood vessel exposed by the ulcer, so that an enormous quantity of blood is rapidly lost, or where the ulcer penetrates right through the wall, spilling the gastric contents into the sterile abdominal cavity. (yogamag.net)
  • As a result, the mucosal resistance of the gastric or duodenal wall diminishes and the acid begins to auto-digest the wall. (yogamag.net)
  • Does the rapid healing of duodenal ulcers mean longer remissions? (who.int)
  • The patient may have a history of previous peptic ulcer and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). (mhmedical.com)
  • Most people with peptic ulcers have these bacteria living in their digestive tract. (medlineplus.gov)
  • Yet, many people who have these bacteria in their stomach do not develop an ulcer. (medlineplus.gov)
  • We also sought a correlation between the promoter polymorphism of the lipopolysaccharide (LPS) receptor CD14 and the formation of peptic ulcer, because CD14 plays a crucial role in the initiation of the cytokine cascade. (dadamo.com)
  • Famotidine is a H2 receptor blocker which is a kind of anti-ulcer drug (gastroenterology drug). (healthtap.com)
  • Cases of duodenal ulcer admitted to Basra General Hospital for a one-year period prior to economic sanctions were compared with cases admitted in a one-year period during sanctions. (who.int)
  • Posterior wall duodenal ulcer. (medscape.com)
  • Lateral view of a posterior wall ulcer in the same patient as in the previous image. (medscape.com)
  • Anterior wall ulcer in a duodenal cap. (medscape.com)
  • The ulcer itself develops because of constant outpouring of acidic gastric secretions, which ultimately overcome the resistance of the mucus cell lining and begin to burn one or more holes into the wall. (yogamag.net)
  • Thus an ulcer begins, which registers as pain when nerve fibres are exposed, like live electricity wires behind a wall panel. (yogamag.net)
  • Ulcers are fairly common. (uhhospitals.org)
  • The most common ulcer symptom is a dull or burning pain in your belly between your breastbone and your belly button (navel). (uhhospitals.org)